Rank | Gene Set | Z-score |
---|---|---|
1 | * B cell receptor signaling pathway (GO:0050853) | 8.44673980 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.04903345 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.94576394 |
4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.34645737 |
5 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 6.30529516 |
6 | positive regulation of B cell differentiation (GO:0045579) | 6.19301024 |
7 | cytidine metabolic process (GO:0046087) | 6.12850564 |
8 | cytidine catabolic process (GO:0006216) | 6.12850564 |
9 | cytidine deamination (GO:0009972) | 6.12850564 |
10 | cellular response to zinc ion (GO:0071294) | 5.95605662 |
11 | regulation of B cell differentiation (GO:0045577) | 5.92182004 |
12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.26751279 |
13 | B cell proliferation (GO:0042100) | 5.23266630 |
14 | regulation of antigen processing and presentation (GO:0002577) | 5.07180014 |
15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.98203006 |
16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.98203006 |
17 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.86232184 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.82620460 |
19 | negative regulation of cell killing (GO:0031342) | 4.66814097 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66814097 |
21 | B cell mediated immunity (GO:0019724) | 4.56272457 |
22 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.56071144 |
23 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.50686437 |
24 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.50686437 |
25 | detection of bacterium (GO:0016045) | 4.42256196 |
26 | mature B cell differentiation (GO:0002335) | 4.25692825 |
27 | positive thymic T cell selection (GO:0045059) | 4.22454585 |
28 | positive regulation of antigen processing and presentation (GO:0002579) | 4.17006320 |
29 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.15254204 |
30 | regulation of B cell proliferation (GO:0030888) | 4.14847150 |
31 | detection of other organism (GO:0098543) | 4.14790177 |
32 | regulation of B cell apoptotic process (GO:0002902) | 4.07549398 |
33 | negative regulation of B cell proliferation (GO:0030889) | 4.06743915 |
34 | negative regulation of phagocytosis (GO:0050765) | 4.02151707 |
35 | T cell lineage commitment (GO:0002360) | 3.98322142 |
36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.97335613 |
37 | negative regulation of histone methylation (GO:0031061) | 3.92566674 |
38 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.87040282 |
39 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.87040282 |
40 | B cell activation (GO:0042113) | 3.85830011 |
41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.78775439 |
42 | regulation of superoxide anion generation (GO:0032928) | 3.78307067 |
43 | regulation of histone H3-K9 methylation (GO:0051570) | 3.78104070 |
44 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.73010710 |
45 | B cell homeostasis (GO:0001782) | 3.70171805 |
46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.70066313 |
47 | lymphocyte homeostasis (GO:0002260) | 3.66475142 |
48 | germinal center formation (GO:0002467) | 3.62832518 |
49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.61650790 |
50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57624137 |
51 | defense response to protozoan (GO:0042832) | 3.57507265 |
52 | negative regulation of B cell apoptotic process (GO:0002903) | 3.57102144 |
53 | T cell homeostasis (GO:0043029) | 3.55600872 |
54 | ribosomal small subunit assembly (GO:0000028) | 3.55066638 |
55 | negative regulation of gene silencing (GO:0060969) | 3.54581620 |
56 | mature B cell differentiation involved in immune response (GO:0002313) | 3.51904105 |
57 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.51380758 |
58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50782762 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50782762 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50782762 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.50782762 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50782762 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.50782762 |
64 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.50772463 |
65 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.50282882 |
66 | cellular response to type I interferon (GO:0071357) | 3.50267865 |
67 | type I interferon signaling pathway (GO:0060337) | 3.50267865 |
68 | response to type I interferon (GO:0034340) | 3.49059575 |
69 | positive regulation of type 2 immune response (GO:0002830) | 3.48961461 |
70 | serine transport (GO:0032329) | 3.48080757 |
71 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.46279141 |
72 | immunoglobulin mediated immune response (GO:0016064) | 3.45013090 |
73 | positive regulation of B cell proliferation (GO:0030890) | 3.41064534 |
74 | lymph node development (GO:0048535) | 3.40064214 |
75 | B cell differentiation (GO:0030183) | 3.34297419 |
76 | positive regulation of B cell activation (GO:0050871) | 3.34192675 |
77 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33866073 |
78 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.33479154 |
79 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.33479154 |
80 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.33479154 |
81 | somatic diversification of immunoglobulins (GO:0016445) | 3.31848681 |
82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.29845984 |
83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.29273880 |
84 | positive regulation of interferon-alpha production (GO:0032727) | 3.28952030 |
85 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.28353506 |
86 | regulation of B cell activation (GO:0050864) | 3.26564255 |
87 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.26260491 |
88 | V(D)J recombination (GO:0033151) | 3.25170196 |
89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.21778229 |
90 | myeloid cell activation involved in immune response (GO:0002275) | 3.21747973 |
91 | leukocyte homeostasis (GO:0001776) | 3.21347182 |
92 | mast cell activation (GO:0045576) | 3.20192259 |
93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20091062 |
94 | negative thymic T cell selection (GO:0045060) | 3.19579037 |
95 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.18489172 |
96 | T cell selection (GO:0045058) | 3.17739269 |
97 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.16922422 |
98 | positive regulation of immunoglobulin production (GO:0002639) | 3.16283791 |
99 | neutrophil activation (GO:0042119) | 3.16020898 |
100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15012850 |
101 | cellular response to interleukin-15 (GO:0071350) | 3.13296638 |
102 | NIK/NF-kappaB signaling (GO:0038061) | 3.13242748 |
103 | response to interleukin-15 (GO:0070672) | 3.12940410 |
104 | regulation of thymocyte apoptotic process (GO:0070243) | 3.12752123 |
105 | viral transcription (GO:0019083) | 3.11556281 |
106 | T cell migration (GO:0072678) | 3.10630784 |
107 | lymphocyte proliferation (GO:0046651) | 3.09795192 |
108 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.09728872 |
109 | T cell costimulation (GO:0031295) | 3.09678999 |
110 | mononuclear cell proliferation (GO:0032943) | 3.09432164 |
111 | leukocyte aggregation (GO:0070486) | 3.09256328 |
112 | lymphocyte costimulation (GO:0031294) | 3.05795261 |
113 | negative regulation of bone resorption (GO:0045779) | 3.05412525 |
114 | somatic diversification of immune receptors (GO:0002200) | 3.05390047 |
115 | regulation of mast cell degranulation (GO:0043304) | 3.05162444 |
116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04796476 |
117 | regulation of interferon-alpha production (GO:0032647) | 3.04741361 |
118 | regulation of chromatin silencing (GO:0031935) | 3.04219353 |
119 | response to protozoan (GO:0001562) | 3.03789767 |
120 | adaptive immune response (GO:0002250) | 3.03598312 |
121 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.03094165 |
122 | thymic T cell selection (GO:0045061) | 3.00055850 |
123 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.99957665 |
124 | neutrophil activation involved in immune response (GO:0002283) | 2.99785463 |
125 | respiratory burst (GO:0045730) | 2.99432791 |
126 | negative regulation of T cell apoptotic process (GO:0070233) | 2.99105906 |
127 | B cell activation involved in immune response (GO:0002312) | 2.98575510 |
128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98251656 |
129 | positive regulation of Rap GTPase activity (GO:0032854) | 2.97342193 |
130 | L-serine transport (GO:0015825) | 2.97119693 |
131 | mast cell activation involved in immune response (GO:0002279) | 2.95853981 |
132 | mast cell degranulation (GO:0043303) | 2.95853981 |
133 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.94501469 |
134 | negative T cell selection (GO:0043383) | 2.91481954 |
135 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.90529682 |
136 | complement activation, classical pathway (GO:0006958) | 2.90399160 |
137 | histamine secretion (GO:0001821) | 2.88216640 |
138 | translational termination (GO:0006415) | 2.86858851 |
139 | hepatocyte apoptotic process (GO:0097284) | 2.86846302 |
140 | positive T cell selection (GO:0043368) | 2.83608608 |
141 | macrophage activation involved in immune response (GO:0002281) | 2.83343368 |
142 | natural killer cell differentiation (GO:0001779) | 2.82010390 |
143 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.81677513 |
144 | Peyers patch development (GO:0048541) | 2.81677513 |
145 | somatic cell DNA recombination (GO:0016444) | 2.81482127 |
146 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.81482127 |
147 | regulation of germinal center formation (GO:0002634) | 2.79999689 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.15558649 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.12042668 |
3 | * MYC_22102868_ChIP-Seq_BL_Human | 4.67152322 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.47800992 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.36392968 |
6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.15685934 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77891976 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.37087888 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.34364288 |
10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.08101800 |
11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99474725 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89969192 |
13 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.79199983 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57581277 |
15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.46165385 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44165966 |
17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39588628 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 2.37980012 |
19 | MYB_26560356_Chip-Seq_TH2_Human | 2.32706237 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28775449 |
21 | MYB_26560356_Chip-Seq_TH1_Human | 2.28515925 |
22 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.28154903 |
23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26169049 |
24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.22549221 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17308145 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15770779 |
27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06257212 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04871997 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98239583 |
30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85914644 |
31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85212528 |
32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84711550 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79820070 |
34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78625876 |
35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76880615 |
36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76867926 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69828506 |
38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69492032 |
39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67405425 |
40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67392138 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65722904 |
42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62764103 |
43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59581341 |
44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.59343692 |
45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59277341 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55222130 |
47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54287417 |
48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53793755 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.52928408 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50155817 |
51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49461612 |
52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47644777 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47036608 |
54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46159919 |
55 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46130315 |
56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43410570 |
57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43073037 |
58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37811062 |
59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36716228 |
60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33725566 |
61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33407384 |
62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.33120632 |
63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32432851 |
64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31797398 |
65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28151741 |
66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27289610 |
67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26481765 |
68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26326598 |
69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25325397 |
70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24526617 |
71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18570566 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17877203 |
73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17832406 |
74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17752633 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17747253 |
76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17237924 |
77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15024411 |
78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08906627 |
79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07608376 |
80 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05740339 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03688396 |
82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03378679 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00551695 |
84 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99230583 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99214552 |
86 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.98074264 |
87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97012508 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94504012 |
89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94422870 |
90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93143165 |
91 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.92973809 |
92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92621205 |
93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90024459 |
94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.89353309 |
95 | P300_27268052_Chip-Seq_Bcells_Human | 0.89030153 |
96 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88312414 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85812762 |
98 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85250273 |
99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84748304 |
100 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84500270 |
101 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84094097 |
102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82509078 |
103 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.81965654 |
104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.81823238 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81685619 |
106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81616319 |
107 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.81586960 |
108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80642415 |
109 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80630248 |
110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80210401 |
111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.79659856 |
112 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79561128 |
113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79291031 |
114 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78341135 |
115 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.77226630 |
116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.76439178 |
117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75503610 |
118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.74804202 |
119 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74342666 |
120 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.73815341 |
121 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.73592574 |
122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73363827 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.64525243 |
2 | * MP0001800_abnormal_humoral_immune | 4.94640931 |
3 | * MP0001790_abnormal_immune_system | 4.34655302 |
4 | * MP0005387_immune_system_phenotype | 4.34655302 |
5 | MP0000685_abnormal_immune_system | 4.03697769 |
6 | * MP0002452_abnormal_antigen_presenting | 3.75356708 |
7 | MP0003303_peritoneal_inflammation | 3.32306493 |
8 | MP0005000_abnormal_immune_tolerance | 3.14784281 |
9 | * MP0002723_abnormal_immune_serum | 3.11107665 |
10 | * MP0002420_abnormal_adaptive_immunity | 3.10954760 |
11 | MP0005671_abnormal_response_to | 3.10528910 |
12 | * MP0002398_abnormal_bone_marrow | 3.09156094 |
13 | * MP0001819_abnormal_immune_cell | 3.01060683 |
14 | MP0002138_abnormal_hepatobiliary_system | 2.83164427 |
15 | * MP0000716_abnormal_immune_system | 2.76856995 |
16 | * MP0000689_abnormal_spleen_morphology | 2.74966645 |
17 | MP0002396_abnormal_hematopoietic_system | 2.45061249 |
18 | MP0003763_abnormal_thymus_physiology | 2.42209772 |
19 | * MP0002722_abnormal_immune_system | 2.32561104 |
20 | * MP0002429_abnormal_blood_cell | 2.31626158 |
21 | MP0002166_altered_tumor_susceptibility | 2.26140763 |
22 | MP0005025_abnormal_response_to | 2.13788360 |
23 | MP0009785_altered_susceptibility_to | 2.04295103 |
24 | MP0004808_abnormal_hematopoietic_stem | 1.97291209 |
25 | MP0005451_abnormal_body_composition | 1.96961116 |
26 | MP0002148_abnormal_hypersensitivity_rea | 1.95879752 |
27 | MP0003724_increased_susceptibility_to | 1.94428177 |
28 | MP0010094_abnormal_chromosome_stability | 1.94255224 |
29 | MP0002419_abnormal_innate_immunity | 1.85872600 |
30 | MP0008057_abnormal_DNA_replication | 1.84444519 |
31 | MP0000703_abnormal_thymus_morphology | 1.82137145 |
32 | MP0006054_spinal_hemorrhage | 1.82079499 |
33 | MP0003436_decreased_susceptibility_to | 1.81636629 |
34 | MP0003300_gastrointestinal_ulcer | 1.81375066 |
35 | MP0002405_respiratory_system_inflammati | 1.74244868 |
36 | MP0001873_stomach_inflammation | 1.70396112 |
37 | MP0001845_abnormal_inflammatory_respons | 1.62661752 |
38 | MP0010155_abnormal_intestine_physiology | 1.62506870 |
39 | MP0001853_heart_inflammation | 1.56376715 |
40 | MP0003172_abnormal_lysosome_physiology | 1.54864443 |
41 | MP0003077_abnormal_cell_cycle | 1.53859290 |
42 | MP0002006_tumorigenesis | 1.52031199 |
43 | MP0004947_skin_inflammation | 1.49602405 |
44 | MP0002933_joint_inflammation | 1.43154065 |
45 | MP0002019_abnormal_tumor_incidence | 1.41850856 |
46 | MP0003866_abnormal_defecation | 1.41551610 |
47 | MP0004510_myositis | 1.41251886 |
48 | MP0005464_abnormal_platelet_physiology | 1.39739495 |
49 | MP0001879_abnormal_lymphatic_vessel | 1.34369828 |
50 | MP0003693_abnormal_embryo_hatching | 1.31464709 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.29130386 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.24458717 |
53 | MP0005310_abnormal_salivary_gland | 1.22885301 |
54 | MP0001849_ear_inflammation | 1.20184698 |
55 | MP0003111_abnormal_nucleus_morphology | 1.17578787 |
56 | MP0003183_abnormal_peptide_metabolism | 1.14426532 |
57 | MP0002009_preneoplasia | 1.12530002 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.07381694 |
59 | MP0000490_abnormal_crypts_of | 1.04234036 |
60 | MP0004381_abnormal_hair_follicle | 1.04228607 |
61 | MP0010234_abnormal_vibrissa_follicle | 1.02039979 |
62 | MP0004957_abnormal_blastocyst_morpholog | 0.96550261 |
63 | MP0009278_abnormal_bone_marrow | 0.96050625 |
64 | MP0002136_abnormal_kidney_physiology | 0.94043831 |
65 | MP0002095_abnormal_skin_pigmentation | 0.93642624 |
66 | MP0005397_hematopoietic_system_phenotyp | 0.93357987 |
67 | MP0001545_abnormal_hematopoietic_system | 0.93357987 |
68 | MP0005174_abnormal_tail_pigmentation | 0.92337434 |
69 | MP0002876_abnormal_thyroid_physiology | 0.91506156 |
70 | MP0005645_abnormal_hypothalamus_physiol | 0.90702217 |
71 | MP0008469_abnormal_protein_level | 0.87424436 |
72 | MP0000350_abnormal_cell_proliferation | 0.86306035 |
73 | MP0008058_abnormal_DNA_repair | 0.85809399 |
74 | MP0003252_abnormal_bile_duct | 0.75229830 |
75 | MP0000313_abnormal_cell_death | 0.74482332 |
76 | MP0003091_abnormal_cell_migration | 0.66327240 |
77 | MP0000015_abnormal_ear_pigmentation | 0.64577089 |
78 | MP0001730_embryonic_growth_arrest | 0.64116102 |
79 | MP0005076_abnormal_cell_differentiation | 0.63956933 |
80 | MP0005621_abnormal_cell_physiology | 0.62878169 |
81 | MP0000013_abnormal_adipose_tissue | 0.62863948 |
82 | MP0001986_abnormal_taste_sensitivity | 0.61122233 |
83 | MP0008874_decreased_physiological_sensi | 0.59693195 |
84 | MP0001663_abnormal_digestive_system | 0.59594546 |
85 | MP0010307_abnormal_tumor_latency | 0.59087190 |
86 | MP0003787_abnormal_imprinting | 0.59019174 |
87 | MP0008260_abnormal_autophagy | 0.57996854 |
88 | MP0008007_abnormal_cellular_replicative | 0.57932035 |
89 | MP0004084_abnormal_cardiac_muscle | 0.57432495 |
90 | MP0002083_premature_death | 0.56159767 |
91 | MP0004036_abnormal_muscle_relaxation | 0.54914276 |
92 | MP0005381_digestive/alimentary_phenotyp | 0.54722489 |
93 | MP0008961_abnormal_basal_metabolism | 0.53980262 |
94 | MP0002928_abnormal_bile_duct | 0.53372224 |
95 | MP0001533_abnormal_skeleton_physiology | 0.53272669 |
96 | MP0000858_altered_metastatic_potential | 0.52892833 |
97 | MP0000249_abnormal_blood_vessel | 0.52809768 |
98 | MP0003045_fibrosis | 0.52059675 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51536911 |
100 | MP0003943_abnormal_hepatobiliary_system | 0.48338171 |
101 | MP0009931_abnormal_skin_appearance | 0.48254131 |
102 | MP0003566_abnormal_cell_adhesion | 0.47730223 |
103 | MP0006082_CNS_inflammation | 0.47699974 |
104 | MP0001851_eye_inflammation | 0.47305055 |
105 | MP0000477_abnormal_intestine_morphology | 0.47289895 |
106 | MP0008004_abnormal_stomach_pH | 0.46898770 |
107 | MP0009763_increased_sensitivity_to | 0.46433686 |
108 | MP0005075_abnormal_melanosome_morpholog | 0.44168953 |
109 | MP0002132_abnormal_respiratory_system | 0.44137090 |
110 | MP0000372_irregular_coat_pigmentation | 0.43881101 |
111 | MP0005384_cellular_phenotype | 0.43824981 |
112 | MP0003191_abnormal_cellular_cholesterol | 0.43188399 |
113 | MP0004883_abnormal_blood_vessel | 0.42213178 |
114 | MP0008877_abnormal_DNA_methylation | 0.42155516 |
115 | MP0000598_abnormal_liver_morphology | 0.42031463 |
116 | MP0001191_abnormal_skin_condition | 0.42026464 |
117 | MP0002693_abnormal_pancreas_physiology | 0.41968243 |
118 | MP0002998_abnormal_bone_remodeling | 0.41713882 |
119 | MP0002139_abnormal_hepatobiliary_system | 0.41689217 |
120 | MP0009764_decreased_sensitivity_to | 0.41067415 |
121 | MP0005166_decreased_susceptibility_to | 0.40507605 |
122 | MP0000569_abnormal_digit_pigmentation | 0.40200842 |
123 | MP0000470_abnormal_stomach_morphology | 0.39880927 |
124 | MP0001764_abnormal_homeostasis | 0.39389011 |
125 | MP0000609_abnormal_liver_physiology | 0.34645834 |
126 | MP0000371_diluted_coat_color | 0.33698012 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Agammaglobulinemia (HP:0004432) | 8.80421288 |
2 | Gastrointestinal stroma tumor (HP:0100723) | 7.84924280 |
3 | Recurrent sinusitis (HP:0011108) | 6.42645279 |
4 | * Cellulitis (HP:0100658) | 6.10176034 |
5 | Colitis (HP:0002583) | 5.97876031 |
6 | * Papilloma (HP:0012740) | 5.55009277 |
7 | * Verrucae (HP:0200043) | 5.55009277 |
8 | IgM deficiency (HP:0002850) | 5.31514381 |
9 | Recurrent viral infections (HP:0004429) | 5.27481818 |
10 | Panhypogammaglobulinemia (HP:0003139) | 5.18406452 |
11 | B lymphocytopenia (HP:0010976) | 5.16076761 |
12 | Abnormality of B cell number (HP:0010975) | 5.16076761 |
13 | * Recurrent bronchitis (HP:0002837) | 5.12292327 |
14 | Lymphopenia (HP:0001888) | 5.10667033 |
15 | Inflammation of the large intestine (HP:0002037) | 5.02397089 |
16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.93320410 |
17 | Gastrointestinal inflammation (HP:0004386) | 4.93066304 |
18 | Emphysema (HP:0002097) | 4.63334912 |
19 | Small epiphyses (HP:0010585) | 4.62410418 |
20 | * Meningitis (HP:0001287) | 4.47517571 |
21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.46166710 |
22 | Hypoproteinemia (HP:0003075) | 4.41106564 |
23 | Thyroiditis (HP:0100646) | 4.40325752 |
24 | IgA deficiency (HP:0002720) | 4.19253893 |
25 | Chronic otitis media (HP:0000389) | 4.00549424 |
26 | Vasculitis (HP:0002633) | 3.95491480 |
27 | IgG deficiency (HP:0004315) | 3.83627654 |
28 | Restrictive lung disease (HP:0002091) | 3.70896178 |
29 | * Recurrent lower respiratory tract infections (HP:0002783) | 3.56698126 |
30 | * Osteomyelitis (HP:0002754) | 3.55506368 |
31 | Recurrent fungal infections (HP:0002841) | 3.49279361 |
32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24350819 |
33 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.22080606 |
34 | * Sepsis (HP:0100806) | 3.21492853 |
35 | Vertebral arch anomaly (HP:0008438) | 3.21266420 |
36 | Mitral stenosis (HP:0001718) | 3.21216693 |
37 | * Recurrent pneumonia (HP:0006532) | 3.20134482 |
38 | * Recurrent otitis media (HP:0000403) | 3.19595458 |
39 | Recurrent abscess formation (HP:0002722) | 3.17229458 |
40 | Abnormality of macrophages (HP:0004311) | 3.14163435 |
41 | Recurrent bacterial skin infections (HP:0005406) | 3.10199731 |
42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05548691 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05548691 |
44 | Lymphoma (HP:0002665) | 3.05404559 |
45 | Leukocytosis (HP:0001974) | 3.03453260 |
46 | Abnormality of T cell physiology (HP:0011840) | 3.03320669 |
47 | Abnormality of T cells (HP:0002843) | 3.03031462 |
48 | Autoimmune thrombocytopenia (HP:0001973) | 2.95712954 |
49 | Flattened epiphyses (HP:0003071) | 2.94472999 |
50 | Abnormality of the fingertips (HP:0001211) | 2.92737695 |
51 | Leukopenia (HP:0001882) | 2.89488072 |
52 | Abnormality of T cell number (HP:0011839) | 2.84596000 |
53 | T lymphocytopenia (HP:0005403) | 2.82370446 |
54 | Thrombocytosis (HP:0001894) | 2.81563927 |
55 | * Bronchitis (HP:0012387) | 2.80931260 |
56 | Abnormality of the prostate (HP:0008775) | 2.78189597 |
57 | Viral hepatitis (HP:0006562) | 2.73073553 |
58 | Combined immunodeficiency (HP:0005387) | 2.65146305 |
59 | Mediastinal lymphadenopathy (HP:0100721) | 2.64914335 |
60 | Recurrent skin infections (HP:0001581) | 2.61349310 |
61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58209209 |
62 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.55644938 |
63 | Absent epiphyses (HP:0010577) | 2.55644938 |
64 | Neutropenia (HP:0001875) | 2.55192539 |
65 | Abnormality of the intervertebral disk (HP:0005108) | 2.49647428 |
66 | Severe combined immunodeficiency (HP:0004430) | 2.49005393 |
67 | Irregular vertebral endplates (HP:0003301) | 2.45938030 |
68 | Hypoplasia of the thymus (HP:0000778) | 2.35961617 |
69 | Ulnar bowing (HP:0003031) | 2.34487262 |
70 | Interstitial pulmonary disease (HP:0006530) | 2.33188572 |
71 | * Skin rash (HP:0000988) | 2.32534587 |
72 | * Chronic sinusitis (HP:0011109) | 2.32530684 |
73 | Erythroderma (HP:0001019) | 2.26569764 |
74 | Urticaria (HP:0001025) | 2.25319202 |
75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25147611 |
76 | Encephalitis (HP:0002383) | 2.24868776 |
77 | Eosinophilia (HP:0001880) | 2.21864222 |
78 | Gastrointestinal infarctions (HP:0005244) | 2.21450210 |
79 | Arthropathy (HP:0003040) | 2.20299905 |
80 | Chronic diarrhea (HP:0002028) | 2.18810968 |
81 | Stomatitis (HP:0010280) | 2.16874065 |
82 | Myositis (HP:0100614) | 2.07765493 |
83 | Nasal polyposis (HP:0100582) | 2.06688960 |
84 | Spontaneous hematomas (HP:0007420) | 2.06536982 |
85 | * Skin ulcer (HP:0200042) | 2.04577292 |
86 | Eczematoid dermatitis (HP:0000976) | 2.02511199 |
87 | Obstructive lung disease (HP:0006536) | 2.02276802 |
88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02276802 |
89 | Increased IgE level (HP:0003212) | 2.02238251 |
90 | Basal cell carcinoma (HP:0002671) | 2.01707672 |
91 | Chest pain (HP:0100749) | 2.00593264 |
92 | Granulocytopenia (HP:0001913) | 1.99724130 |
93 | Abnormality of the pleura (HP:0002103) | 1.99235239 |
94 | Increased IgM level (HP:0003496) | 1.95644888 |
95 | Papilledema (HP:0001085) | 1.92778334 |
96 | Pustule (HP:0200039) | 1.92734407 |
97 | Autoimmune hemolytic anemia (HP:0001890) | 1.92505855 |
98 | Abnormality of the peritoneum (HP:0002585) | 1.91122591 |
99 | Arthralgia (HP:0002829) | 1.89491949 |
100 | Fatigue (HP:0012378) | 1.87663060 |
101 | Optic neuritis (HP:0100653) | 1.87423438 |
102 | Retrobulbar optic neuritis (HP:0100654) | 1.87423438 |
103 | Gingivitis (HP:0000230) | 1.84895798 |
104 | Abnormality of eosinophils (HP:0001879) | 1.82434832 |
105 | Prolonged bleeding time (HP:0003010) | 1.81412508 |
106 | Abnormality of the vertebral endplates (HP:0005106) | 1.79848246 |
107 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.79359492 |
108 | Orchitis (HP:0100796) | 1.77048025 |
109 | Prostate neoplasm (HP:0100787) | 1.75755509 |
110 | Abnormality of male internal genitalia (HP:0000022) | 1.74023272 |
111 | Barrel-shaped chest (HP:0001552) | 1.73763620 |
112 | Abnormality of the nasal mucosa (HP:0000433) | 1.73500570 |
113 | Limited elbow extension (HP:0001377) | 1.73500090 |
114 | Pulmonary fibrosis (HP:0002206) | 1.72222765 |
115 | Cellular immunodeficiency (HP:0005374) | 1.70189861 |
116 | Hematochezia (HP:0002573) | 1.70059338 |
117 | Reticulocytopenia (HP:0001896) | 1.68770915 |
118 | Aortic regurgitation (HP:0001659) | 1.68338873 |
119 | Pulmonary infiltrates (HP:0002113) | 1.66381577 |
120 | Hemoptysis (HP:0002105) | 1.66345307 |
121 | Epistaxis (HP:0000421) | 1.64471337 |
122 | Hypochromic anemia (HP:0001931) | 1.63567780 |
123 | Progressive external ophthalmoplegia (HP:0000590) | 1.63022374 |
124 | Hypergammaglobulinemia (HP:0010702) | 1.62067254 |
125 | Hepatitis (HP:0012115) | 1.61931832 |
126 | Petechiae (HP:0000967) | 1.60593043 |
127 | Villous atrophy (HP:0011473) | 1.60365773 |
128 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.60365773 |
129 | Keratoconjunctivitis sicca (HP:0001097) | 1.57503907 |
130 | Abnormality of the thymus (HP:0000777) | 1.57442976 |
131 | Hypertensive crisis (HP:0100735) | 1.57336862 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 6.52488618 |
2 | MAP3K10 | 5.40454704 |
3 | GRK6 | 3.66895853 |
4 | ERN1 | 3.43865856 |
5 | BLK | 3.13939676 |
6 | SYK | 3.01523439 |
7 | CSF1R | 2.95831171 |
8 | BTK | 2.71874001 |
9 | RIPK4 | 2.30335229 |
10 | LRRK2 | 2.16435326 |
11 | STK10 | 2.14473176 |
12 | EEF2K | 1.96829445 |
13 | SIK2 | 1.76647360 |
14 | PRPF4B | 1.67774024 |
15 | MAP3K13 | 1.64128133 |
16 | * LYN | 1.57703374 |
17 | TYK2 | 1.56456141 |
18 | MAP3K14 | 1.53787105 |
19 | BMPR2 | 1.50884090 |
20 | EIF2AK3 | 1.47911338 |
21 | KIT | 1.45509512 |
22 | CLK1 | 1.35636355 |
23 | NEK2 | 1.31005615 |
24 | HCK | 1.30650837 |
25 | CDK12 | 1.27658476 |
26 | TBK1 | 1.26235789 |
27 | MST4 | 1.26157134 |
28 | TEC | 1.25100240 |
29 | TLK1 | 1.19882012 |
30 | JAK1 | 1.18893106 |
31 | TXK | 1.18050992 |
32 | PIK3CG | 1.16114510 |
33 | FES | 1.15496896 |
34 | TAOK3 | 1.15392125 |
35 | CDK8 | 1.14245821 |
36 | MAP3K11 | 1.13354655 |
37 | CSK | 1.12549093 |
38 | ITK | 1.12539632 |
39 | PIM1 | 1.07987749 |
40 | ZAP70 | 1.07114054 |
41 | PRKCH | 1.06679190 |
42 | STK4 | 1.06436512 |
43 | CDK4 | 1.03727107 |
44 | GRK1 | 1.02150651 |
45 | KDR | 1.00817776 |
46 | MARK3 | 1.00331588 |
47 | PRKCQ | 0.99706368 |
48 | IKBKB | 0.98900973 |
49 | BMPR1B | 0.98130862 |
50 | MATK | 0.89047220 |
51 | TRIB3 | 0.89020565 |
52 | SMG1 | 0.87830531 |
53 | ARAF | 0.85942107 |
54 | SIK3 | 0.85293730 |
55 | RPS6KA4 | 0.84854992 |
56 | JAK3 | 0.83239316 |
57 | TNK2 | 0.81917754 |
58 | IRAK4 | 0.79838653 |
59 | IKBKE | 0.78606331 |
60 | * LCK | 0.77133376 |
61 | BRD4 | 0.75139798 |
62 | CDC7 | 0.74765534 |
63 | CCNB1 | 0.74669550 |
64 | TGFBR2 | 0.71651299 |
65 | TAOK1 | 0.69639379 |
66 | PKN2 | 0.69015421 |
67 | RPS6KB2 | 0.68960351 |
68 | IRAK3 | 0.68137652 |
69 | FGFR3 | 0.67212874 |
70 | CDK9 | 0.65294419 |
71 | HIPK2 | 0.64388344 |
72 | MAPK12 | 0.64146939 |
73 | MAPK7 | 0.63687420 |
74 | DYRK1B | 0.61266524 |
75 | BUB1 | 0.59366419 |
76 | MELK | 0.59356176 |
77 | MARK2 | 0.56927478 |
78 | PRKCI | 0.56830494 |
79 | PRKD2 | 0.55470489 |
80 | DYRK3 | 0.54495188 |
81 | TESK2 | 0.53929046 |
82 | MAP2K3 | 0.53711025 |
83 | MAPK4 | 0.53582189 |
84 | MAP3K8 | 0.53476982 |
85 | SCYL2 | 0.53174482 |
86 | SIK1 | 0.52816266 |
87 | MAPK11 | 0.51530517 |
88 | ALK | 0.50945376 |
89 | RPS6KC1 | 0.49227841 |
90 | RPS6KL1 | 0.49227841 |
91 | CDC42BPA | 0.48735356 |
92 | CHUK | 0.48201368 |
93 | MAP3K3 | 0.48042627 |
94 | JAK2 | 0.47717730 |
95 | MAP3K1 | 0.46745568 |
96 | MAP3K7 | 0.46724381 |
97 | TAOK2 | 0.46618406 |
98 | PRKD1 | 0.46176227 |
99 | MAP2K2 | 0.45440906 |
100 | CDK19 | 0.45426024 |
101 | ABL1 | 0.45110463 |
102 | FRK | 0.44370131 |
103 | RPS6KB1 | 0.43352801 |
104 | NLK | 0.42369853 |
105 | RPS6KA6 | 0.42183966 |
106 | ATR | 0.41162188 |
107 | PDK1 | 0.40824996 |
108 | MAPKAPK3 | 0.39687998 |
109 | EIF2AK1 | 0.38523004 |
110 | INSR | 0.38479151 |
111 | PASK | 0.37959493 |
112 | CHEK1 | 0.35739044 |
113 | PRKCD | 0.35569421 |
114 | CDK7 | 0.35219411 |
115 | MAP2K1 | 0.31373327 |
116 | CSNK1A1L | 0.31368559 |
117 | CSNK1G1 | 0.31366236 |
118 | FGR | 0.30022877 |
119 | FGFR4 | 0.29762435 |
120 | DAPK1 | 0.29145005 |
121 | CSNK1D | 0.29011716 |
122 | PDPK1 | 0.27528146 |
123 | AURKB | 0.26850635 |
124 | TGFBR1 | 0.26403486 |
125 | MAPK3 | 0.26160882 |
126 | CSNK1G3 | 0.25200923 |
127 | MAPKAPK2 | 0.24550111 |
128 | WNK1 | 0.24507779 |
129 | MAPK13 | 0.24018097 |
130 | * FYN | 0.23083685 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.94326739 |
2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.49243788 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.08568294 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95801008 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.33385184 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.04677654 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.84153554 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.70872938 |
9 | DNA replication_Homo sapiens_hsa03030 | 2.64687601 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59718425 |
11 | Mismatch repair_Homo sapiens_hsa03430 | 2.59659834 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.55364522 |
13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.48906936 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21466686 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.14407384 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88881372 |
17 | Ribosome_Homo sapiens_hsa03010 | 1.79853024 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.78480662 |
19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66398388 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61065689 |
21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.58517123 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43664206 |
23 | Homologous recombination_Homo sapiens_hsa03440 | 1.41597099 |
24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40185012 |
25 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.37748674 |
26 | Measles_Homo sapiens_hsa05162 | 1.33029447 |
27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31889325 |
28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26553320 |
29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23117268 |
30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20164755 |
31 | Tuberculosis_Homo sapiens_hsa05152 | 1.17949504 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16440010 |
33 | Spliceosome_Homo sapiens_hsa03040 | 1.16289181 |
34 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11320956 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.11204782 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08335645 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07013489 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.05280873 |
39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04527312 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.03885324 |
41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02262288 |
42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97384994 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93432884 |
44 | Apoptosis_Homo sapiens_hsa04210 | 0.93380925 |
45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90954400 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89667371 |
47 | Influenza A_Homo sapiens_hsa05164 | 0.89441796 |
48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88310179 |
49 | Phagosome_Homo sapiens_hsa04145 | 0.88099295 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85459656 |
51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85191907 |
52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85036277 |
53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83966976 |
54 | Cell cycle_Homo sapiens_hsa04110 | 0.82004785 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80987715 |
56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76284938 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75530495 |
58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74143711 |
59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68994590 |
60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68517944 |
61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64075986 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62661995 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62107720 |
64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60867292 |
65 | Alcoholism_Homo sapiens_hsa05034 | 0.59947571 |
66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56062255 |
67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56048134 |
68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55946227 |
69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54984585 |
70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54367104 |
71 | RNA transport_Homo sapiens_hsa03013 | 0.49935368 |
72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49318176 |
73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48825682 |
74 | Glioma_Homo sapiens_hsa05214 | 0.47952685 |
75 | Pertussis_Homo sapiens_hsa05133 | 0.47005863 |
76 | Allograft rejection_Homo sapiens_hsa05330 | 0.46937441 |
77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46876352 |
78 | Salmonella infection_Homo sapiens_hsa05132 | 0.46458279 |
79 | Legionellosis_Homo sapiens_hsa05134 | 0.45955180 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45597972 |
81 | Hepatitis C_Homo sapiens_hsa05160 | 0.44409117 |
82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43838040 |
83 | RNA degradation_Homo sapiens_hsa03018 | 0.42163820 |
84 | Malaria_Homo sapiens_hsa05144 | 0.41859016 |
85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40580663 |
86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39161120 |
87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39069476 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38679673 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.38328449 |
90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38030409 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37886098 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36594470 |
93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36169698 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.35237436 |
95 | Asthma_Homo sapiens_hsa05310 | 0.32578432 |
96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32542604 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.31488013 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.30568583 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28314488 |
100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.27454586 |
101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23782062 |
102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23474100 |
103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23462026 |
104 | RNA polymerase_Homo sapiens_hsa03020 | 0.23249848 |
105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22933706 |
106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22871239 |
107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20245619 |
108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19401690 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18497441 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17973971 |
111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17745966 |
112 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.17367006 |
113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17288980 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16516647 |
115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14877176 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13458590 |
117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11678003 |
118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.09717020 |
119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.06815305 |
120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00503281 |